Emergent BioSolutions Inc

NetDania - New 12 months High: Emergent BioSolutions Inc

19 Sep 2018 10:04:05 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

18 Sep 2018 09:44:47 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

17 Sep 2018 09:53:11 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

14 Sep 2018 11:28:24 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

30 Aug 2018 09:47:31 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

29 Aug 2018 09:44:13 By NetDania Notify

Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray

28 Aug 2018 16:30:57 By Nasdaq GlobeNewswire

NetDania - New 12 months High: Emergent BioSolutions Inc

28 Aug 2018 15:16:48 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

27 Aug 2018 12:03:29 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

24 Aug 2018 10:04:08 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

23 Aug 2018 09:44:57 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

22 Aug 2018 09:52:28 By NetDania Notify

NetDania - New 12 months High: Emergent BioSolutions Inc

21 Aug 2018 11:39:24 By NetDania Notify

Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences

17 Aug 2018 07:00:20 By Nasdaq GlobeNewswire

CEPI Awards Contract Worth up to $36 million to Profectus BioSciences and Emergent BioSolutions to Develop Lassa Virus Vaccine

16 Aug 2018 06:15:15 By Nasdaq GlobeNewswire

Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax

09 Aug 2018 06:30:19 By Nasdaq GlobeNewswire

NetDania - New 12 months High: Emergent BioSolutions Inc

03 Aug 2018 09:46:19 By NetDania Notify

Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months of 2018

02 Aug 2018 16:30:31 By Nasdaq GlobeNewswire

Emergent BioSolutions Initiates Phase 1 Clinical Study of Zika Virus Immune Globulin Therapeutic

31 Jul 2018 16:30:37 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Second Quarter 2018 Financial Results and Conduct a Conference Call on August 2, 2018

18 Jul 2018 16:30:33 By Nasdaq GlobeNewswire